A Phase I Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses and Treatment Intensification of a Vaccine-Based Immunotherapy Regimen-2 VBIR-2 PF-06936308 For Advanced Non-Small Cell Lung Cancer and Metastatic Triple-Negative Breast Cancer

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03674827

Study #:
STUDY00142942

Start Date:
Feb 04, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03674827

View Complete Trial Details & Eligibility at ClinicalTrials.gov